Joinn Laboratories (China) Co.,Ltd. Stock OTC Markets
Stocks
JNNL.Y
US47972L1089
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 29.49B 4.39B 3.78B 3.56B 3.24B 6.07B 418B 6.09B 42.2B 16.31B 213B 16.5B 16.14B 675B | P/E 2026 * |
36x | P/E 2027 * | 54.6x |
|---|---|---|---|---|---|
| Enterprise Value | 27.61B 4.11B 3.54B 3.33B 3.04B 5.68B 391B 5.71B 39.5B 15.27B 199B 15.45B 15.11B 632B | EV / Sales 2026 * |
14.9x | EV / Sales 2027 * | 12.9x |
| Free-Float |
64.87% | Yield 2026 * |
0.78% | Yield 2027 * | 0.38% |
| Manager | Title | Age | Since |
|---|---|---|---|
Da Peng Gao
CEO | Chief Executive Officer | 44 | 2019-01-27 |
Ai Shui Yu
DFI | Director of Finance/CFO | 50 | 2020-04-09 |
Jing Liang Gu
PRN | Corporate Officer/Principal | 46 | 2025-01-22 |
| Director | Title | Age | Since |
|---|---|---|---|
Yu Xia Feng
CHM | Chairman | 62 | 1995-08-10 |
Da Peng Gao
BRD | Director/Board Member | 44 | 2012-12-09 |
Ye Li
CHM | Chairman | 44 | 2012-12-09 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 4.39B | |
| +0.84% | -6.98% | -2.73% | +11.12% | 46.38B | |
| +0.17% | -0.74% | +407.28% | +546.58% | 44.51B | |
| -0.86% | -2.60% | +35.51% | +20.35% | 42.3B | |
| -0.14% | -2.98% | -0.04% | +82.21% | 39.91B | |
| 0.00% | -1.72% | +13.42% | +42.33% | 32.79B | |
| -3.44% | -2.43% | - | - | 17.13B | |
| -0.78% | -1.13% | +20.74% | +116.26% | 16.36B | |
| +0.70% | -3.76% | +12.33% | +30.49% | 14.31B | |
| -0.86% | -4.60% | +76.86% | +39.36% | 13.29B | |
| Average | -0.54% | -2.88% | +70.42% | +111.09% | 29.66B | |
| Weighted average by Cap. | -0.31% | -3.04% | +85.97% | +133.03% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.85B 276M 237M 223M 204M 381M 26.23B 382M 2.65B 1.02B 13.36B 1.04B 1.01B 42.33B | 2.12B 315M 271M 256M 233M 436M 30.01B 437M 3.03B 1.17B 15.29B 1.18B 1.16B 48.44B |
| Net income | 767M 114M 98.36M 92.62M 84.39M 158M 10.88B 159M 1.1B 424M 5.54B 429M 420M 17.55B | 381M 56.77M 48.85M 46M 41.91M 78.42M 5.4B 78.73M 545M 211M 2.75B 213M 209M 8.72B |
| Net Debt | -1.89B -281M -242M -228M -207M -388M -26.74B -390M -2.7B -1.04B -13.62B -1.06B -1.03B -43.16B | -2.12B -316M -272M -256M -233M -437M -30.09B -439M -3.04B -1.17B -15.33B -1.19B -1.16B -48.57B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
